Edition:
United States

Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
3:59pm EST
Change (% chg)

$-0.04 (-2.99%)
Prev Close
$1.34
Open
$1.30
Day's High
$1.30
Day's Low
$1.30
Volume
124
Avg. Vol
3,397
52-wk High
$2.87
52-wk Low
$1.27

Latest Key Developments (Source: Significant Developments)

Bioanalytical Systems Q1 Earnings Per Share $0.00
Wednesday, 14 Feb 2018 03:00pm EST 

Feb 14 (Reuters) - Bioanalytical Systems Inc ::Q1 EARNINGS PER SHARE $0.00.‍FOR THREE MONTHS ENDED DECEMBER 31, 2017, REVENUE AMOUNTED TO $5.4 MILLION, 13% DECREASE FROM $6.2 MILLION IN Q1 OF FISCAL 2017​.  Full Article

Bioanalytical Systems reports Q3 earnings per share of $0.03
Monday, 14 Aug 2017 10:53am EDT 

Aug 14 (Reuters) - Bioanalytical Systems Inc ::Q3 earnings per share $0.03.Qtrly ‍revenue amounted to $5.8 million, up 15 percent.  Full Article

Bioanalytical systems inc says entered into credit agreement with First Internet Bank Of Indiana - SEC filing
Tuesday, 27 Jun 2017 10:08am EDT 

June 27 (Reuters) - Bioanalytical Systems Inc :Bioanalytical Systems Inc - entered into a credit agreement with first internet bank of indiana - sec filing.Bioanalytical Systems Inc - credit agreement provides company with a term loan in amount of $4.5 million.Bioanalytical Systems Inc - credit agreement provides co with revolving line of credit of up to $2 million.Bioanalytical Systems Inc - term loan and facility mature June 23, 2022 and June 23, 2019, respectively.  Full Article

BASI reports Q2 earnings per share $0.05
Monday, 15 May 2017 08:30am EDT 

May 15 (Reuters) - Bioanalytical Systems Inc :BASI reports second quarter results.Q2 earnings per share $0.05.Q2 revenue rose 19 percent to $6.359 million.Bioanalytical Systems Inc - board has directed management to seek alternatives that will enable company to repay its indebtedness to Huntington Bank.Bioanalytical Systems-evaluating among others, potential disposition of certain assets, possible sale of West Lafayette building to repay indebtedness.Bioanalytical Systems Inc - board continues to weigh options and timing for hiring a new CEO, to fill position vacated in November of 2016.Bioanalytical Systems Inc- qtrly revenue rose on preclinical services revenues due to an overall rise in number of studies in Q2 versus prior year period.  Full Article

BASI Q1 EPS $0.00
Tuesday, 14 Feb 2017 08:30am EST 

Bioanalytical Systems Inc : BASI reports first quarter results . Q1 earnings per share $0.00 . Q1 revenue rose 26 percent to $6.174 million . Bioanalytical Systems - board has directed management to seek alternatives to enable co to repay indebtedness to Huntington Bank in full . Bioanalytical Systems - continues to explore initiatives to address credit issues, including but not limited to, potential disposition of certain assets . Bioanalytical Systems Inc - company continues to explore initiatives such as possible sale and leaseback of building in West Lafayette, Indiana . Bioanalytical Systems Inc - management has been, and continues to be actively engaged in more effectively controlling operating costs .Bioanalytical Systems Inc - board of directors continues to weigh options for replacing chief executive officer.  Full Article

Bioanalytical Systems says co entered into fifth forbearance agreement and sixth amendment to credit agreement
Wednesday, 1 Feb 2017 01:44pm EST 

Bioanalytical Systems Inc : Bioanalytical Systems - effective Jan 31, co entered into a fifth forbearance agreement and sixth amendment to credit agreement - SEC filing .Bioanalytical Systems Inc - fifth forbearance agreement amends maturity dates for term and revolving loans under credit agreement to July 31, 2017.  Full Article